Connect Biopharma Holdings Limited
CNTB
$2.05
-$0.10-4.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.45M | -18.70M | -17.12M | -21.30M | -25.48M |
| Total Depreciation and Amortization | 528.00K | 519.00K | 510.00K | 524.50K | 539.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.44M | 7.76M | 8.26M | 7.27M | 6.27M |
| Change in Net Operating Assets | 1.29M | -22.87M | -15.57M | -10.89M | -6.21M |
| Cash from Operations | -38.19M | -33.29M | -23.92M | -24.40M | -24.87M |
| Capital Expenditure | -698.00K | -685.00K | -604.00K | -343.00K | -82.00K |
| Sale of Property, Plant, and Equipment | 2.00K | 2.00K | -- | 1.00K | 2.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.54M | -32.48M | -2.66M | 25.38M | 53.43M |
| Cash from Investing | -31.24M | -33.16M | -3.27M | 25.04M | 53.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 148.00K | 148.00K | 148.00K | 146.00K | 144.00K |
| Issuance of Common Stock | 288.00K | 248.00K | 246.00K | 195.00K | 144.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 436.00K | 396.00K | 394.00K | 341.00K | 288.00K |
| Foreign Exchange rate Adjustments | -206.00K | -328.00K | -624.00K | -549.50K | -475.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.20M | -66.38M | -27.42M | 435.50K | 28.29M |